Company profile: MultiCell Technologies
1.1 - Company Overview
Company description
- Provider of biopharmaceutical solutions.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MultiCell Technologies
Affiris
HQ: Austria
Website
- Description: Provider of tailor-made peptide vaccines and specific active immunotherapies for chronic diseases, including Alzheimer’s, Parkinson’s, atherosclerosis/hypercholesterolemia and hypertension. Portfolio includes AFFITOPE PD01/PD03 targeting alpha-synuclein, AFFITOPE AT04/AT06 targeting PCSK9 to lower LDL, mAB C6-17 for mutant huntingtin, and the SAIT modality.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Affiris company profile →
BioNTech
HQ: Germany
Website
- Description: Provider of next-generation immunotherapies for cancer and infectious diseases, including mRNA-based drugs to encode antigens, neoantigens, cytokines and antibodies; engineered cell therapies (CAR-T and TCR); protein therapeutics such as antibodies, bispecifics and antibody-drug conjugates; and small-molecule immunomodulators. Also conducts clinical trials and advances a pipeline of investigational vaccines and immunotherapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioNTech company profile →
Glide Technologies
HQ: United Kingdom
Website
- Description: Provider of convenient delivery solutions for biological medicines, including solid dose formulations of therapeutics and vaccines and the SDI solid dose injector system to improve compliance in self-administered long-term therapy; pipeline includes solid dose octreotide and teriparatide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Glide Technologies company profile →
Arresto Biosciences
HQ: United States
Website
- Description: Provider of medicine development targeting extracellular matrix molecules to treat cancer and fibrotic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arresto Biosciences company profile →
Tobira Therapeutics
HQ: United States
Website
- Description: Provider of research, discovery, acquisition, development, and commercialization of antiviral compounds for treating life-threatening and life-altering infectious diseases, including HIV/AIDS and hepatitis; develops TBR-652 and TBR-220 antagonists.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tobira Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MultiCell Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MultiCell Technologies
2.2 - Growth funds investing in similar companies to MultiCell Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MultiCell Technologies
4.2 - Public trading comparable groups for MultiCell Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →